MAZE
Maze Therapeutics, Inc.
Company overview
- Market capitalization
- $1.49B
- Employees
- 141
- Latest publication
- 2026-09-29
About Maze Therapeutics, Inc.
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule inhibitor that is in phase II ready clinical trial for the treatment of phenylketonuria and chronic kidney disease. The company also develops MZE001, an investigational oral small molecule inhibitor of muscle-specific glycogen synthase clinical program for the treatment of Pompe disease. It has a license agreement with Trace Neuroscience, Inc. to discovery research program targets UNC13A; the Shionogi & Co., Ltd to research, develop, manufacture, and commercialize MZE001; and Neurocrine Biosciences, Inc. to discover research program that targets ATXN2. The company was formerly known as Modulus Therapeutics, Inc. and changed its name to Maze Therapeutics, Inc. in September 2018. The company was incorporated in 2017 and is based in South San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Research Development | 34,940,000USD | 33,704,000USD | 27,570,000USD | 25,190,000USD | 28,108,000USD | 27,580,000USD | 22,216,000USD | 19,857,000USD |
| Total Operating Expenses | 48,035,000USD | 46,109,000USD | 37,560,000USD | 32,965,000USD | 35,825,000USD | 35,401,000USD | 29,726,000USD | 26,729,000USD |
| Net Income | -44,727,000USD | -24,208,000USD | -34,568,000USD | -30,087,000USD | -33,679,000USD | -32,786,000USD | -29,579,000USD | -24,752,000USD |
| Total Revenue | — | 20,000,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 2,500,000USD |
| Cost Of Revenue | — | 444,000USD | 499,000USD | — | 649,000USD | 684,000USD | 705,000USD | 788,000USD |
| Gross Profit | — | 19,556,000USD | -499,000USD | — | -649,000USD | -684,000USD | -705,000USD | 2,500,000USD |
| Selling General Administrative | — | 12,405,000USD | 10,489,000USD | 7,775,000USD | 8,366,000USD | 7,821,000USD | 7,510,000USD | 6,872,000USD |
| Operating Income | — | -26,553,000USD | -38,059,000USD | -32,965,000USD | -36,474,000USD | -35,401,000USD | -29,726,000USD | -24,229,000USD |
| Interest Income | — | 3,211,000USD | 3,491,000USD | 2,878,000USD | 2,795,000USD | 2,615,000USD | 1,516,000USD | 1,846,000USD |
| Interest Expense | — | 866,000USD | — | — | — | 0USD | — | — |
| Net Interest Income | — | 2,345,000USD | 3,491,000USD | 2,878,000USD | 2,795,000USD | 2,615,000USD | 1,516,000USD | 1,846,000USD |
| Income Before Tax | — | -24,208,000USD | -34,568,000USD | -30,087,000USD | -33,679,000USD | -32,786,000USD | -29,854,000USD | -25,031,000USD |
| Net Income From Continuing Ops | — | -24,208,000USD | -34,568,000USD | -30,087,000USD | -33,679,000USD | -32,786,000USD | -29,579,000USD | -24,752,000USD |
| Ebit | — | -26,553,000USD | -38,059,000USD | -30,087,000USD | -33,679,000USD | -35,401,000USD | -29,726,000USD | -24,229,000USD |
| Ebitda | — | -26,109,000USD | -37,560,000USD | -29,516,000USD | -33,030,000USD | -34,717,000USD | -29,021,000USD | -23,441,000USD |
| Depreciation And Amortization | — | 444,000USD | 499,000USD | 571,000USD | 649,000USD | 684,000USD | 705,000USD | 788,000USD |
| Reconciled Depreciation | — | 444,000USD | 499,000USD | 571,000USD | 649,000USD | 684,000USD | 705,000USD | 788,000USD |
| Total Other Income Expense Net | — | 2,345,000USD | 3,491,000USD | 2,878,000USD | 2,795,000USD | 2,615,000USD | -128,000USD | -802,000USD |
| Tax Provision | — | — | 0USD | 0USD | 0USD | — | -275,000USD | -279,000USD |
| Income Tax Expense | — | — | — | — | — | — | -275,000USD | -279,000USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Revenue | 0USD | 167,500,000USD | 0USD | 0USD |
| Cost Of Revenue | 2,403,000USD | 3,297,000USD | 4,089,000USD | 3,820,000USD |
| Gross Profit | -2,403,000USD | 167,500,000USD | -4,089,000USD | -3,820,000USD |
| Research Development | 108,448,000USD | 83,496,000USD | 73,945,000USD | 88,192,000USD |
| Selling General Administrative | 34,451,000USD | 26,418,000USD | 24,606,000USD | 22,834,000USD |
| Unclassified Operating Expenses | -2,403,000USD | — | — | — |
| Total Operating Expenses | 140,496,000USD | 109,914,000USD | 98,551,000USD | 111,026,000USD |
| Operating Income | -142,899,000USD | 57,586,000USD | -98,551,000USD | -111,026,000USD |
| Interest Income | 11,779,000USD | 4,654,000USD | 1,966,000USD | 2,028,000USD |
| Net Interest Income | 11,779,000USD | 4,654,000USD | 1,966,000USD | 2,028,000USD |
| Income Before Tax | -131,120,000USD | 53,403,000USD | -100,415,000USD | -114,940,000USD |
| Tax Provision | 0USD | 1,172,000USD | 0USD | — |
| Net Income | -131,120,000USD | 52,231,000USD | -100,415,000USD | -114,940,000USD |
| Net Income From Continuing Ops | -131,120,000USD | 52,231,000USD | -100,415,000USD | -114,940,000USD |
| Ebit | -142,899,000USD | 57,586,000USD | -98,551,000USD | -111,026,000USD |
| Ebitda | -140,496,000USD | 60,883,000USD | -94,462,000USD | -107,206,000USD |
| Depreciation And Amortization | 2,403,000USD | 3,297,000USD | 4,089,000USD | 3,820,000USD |
| Reconciled Depreciation | 2,403,000USD | 3,297,000USD | 4,089,000USD | 3,820,000USD |
| Total Other Income Expense Net | 11,779,000USD | -4,183,000USD | -1,864,000USD | -3,914,000USD |
| Income Tax Expense | — | 1,172,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 531,625,000USD | 419,710,000USD | 397,127,000USD | 422,058,000USD | 303,519,000USD | 332,840,000USD | 240,542,000USD | 192,480,000USD |
| Cash And Equivalents | 202,643,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 411,087,000USD | 352,382,000USD | 341,917,000USD | 383,935,000USD | 264,541,000USD | 294,374,000USD | 196,812,000USD | 149,607,000USD |
| Short Term Investments | 208,444,000USD | 153,616,000USD | 152,670,000USD | 67,162,000USD | — | — | 0USD | — |
| Long Term Investments | 83,821,000USD | 10,556,000USD | 18,114,000USD | — | — | — | 0USD | — |
| Total Current Assets | 420,423,000USD | 379,779,000USD | 349,717,000USD | 391,302,000USD | 271,150,000USD | 299,707,000USD | 201,671,000USD | 153,956,000USD |
| Other Current Assets | 9,336,000USD | 7,397,000USD | 7,800,000USD | 6,667,000USD | 6,609,000USD | 5,333,000USD | 4,859,000USD | 4,349,000USD |
| Other Non Current Assets | 3,460,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 78,501,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 22,961,000USD | 21,236,000USD | 22,556,000USD | 22,112,000USD | 19,900,000USD | 18,617,000USD | 20,673,000USD | 17,555,000USD |
| Total Stockholder Equity | 453,124,000USD | 341,701,000USD | 354,966,000USD | 379,436,000USD | 262,238,000USD | 292,068,000USD | 196,904,000USD | 99,370,000USD |
| Total Equity Including Noncontrolling Interest | 453,124,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 0USD | — | — | — | — | — | — | — |
| Long Term Debt | 38,960,000USD | 38,833,000USD | — | — | — | — | — | 51,748,000USD |
| Property Plant Equipment Net | 22,833,000USD | 23,967,000USD | 25,160,000USD | 26,458,000USD | 27,713,000USD | 28,797,000USD | 29,918,000USD | 30,932,000USD |
| Accounts Payable | 2,212,000USD | 4,013,000USD | 1,794,000USD | 2,918,000USD | 3,666,000USD | 2,404,000USD | 1,939,000USD | 1,018,000USD |
| Short Term Debt | 4,883,000USD | 4,838,000USD | 4,795,000USD | 4,764,000USD | 4,718,000USD | 4,674,000USD | 4,632,000USD | 4,617,000USD |
| Common Stock | 56,000USD | 50,000USD | 49,000USD | 48,000USD | 44,000USD | 44,000USD | 2,000USD | 23,000USD |
| Retained Earnings | -558,482,000USD | -513,755,000USD | -489,547,000USD | -454,979,000USD | -424,892,000USD | -391,213,000USD | -358,427,000USD | -313,876,000USD |
| Total Liab | — | 78,009,000USD | 42,161,000USD | 42,622,000USD | 41,281,000USD | 40,772,000USD | 43,638,000USD | 93,110,000USD |
| Other Current Liab | — | 12,385,000USD | 15,967,000USD | 14,430,000USD | 11,516,000USD | 11,539,000USD | 14,102,000USD | 11,703,000USD |
| Capital Stock | — | 50,000USD | 49,000USD | 48,000USD | 44,000USD | 44,000USD | 2,000USD | 2,000USD |
| Cash | — | 198,766,000USD | 189,247,000USD | 316,773,000USD | 264,541,000USD | 294,374,000USD | 196,812,000USD | 149,607,000USD |
| Net Debt | — | -137,543,000USD | -165,941,000USD | -292,590,000USD | -239,532,000USD | -268,551,000USD | -170,184,000USD | -70,447,000USD |
| Short Long Term Debt Total | — | 61,223,000USD | 23,306,000USD | 24,183,000USD | 25,009,000USD | 25,823,000USD | 26,628,000USD | 79,160,000USD |
| Net Receivables | — | 20,000,000USD | 1,500,000USD | 700,000USD | — | — | — | — |
| Property Plant Equipment Gross | — | 23,967,000USD | 44,371,000USD | 26,458,000USD | 27,713,000USD | 28,797,000USD | 46,785,000USD | 30,932,000USD |
| Accumulated Other Comprehensive Income | — | -135,000USD | 110,000USD | 69,000USD | — | — | — | — |
| Common Stock Shares Outstanding | — | 53,897,216shares | 42,976,024shares | 45,779,577shares | 43,850,884shares | 43,797,166shares | 43,796,057shares | 43,776,978shares |
| Non Current Assets Total | — | 39,931,000USD | 47,410,000USD | 30,755,999USD | 32,369,000USD | 33,132,999USD | 38,871,000USD | 38,524,000USD |
| Non Current Liabilities Total | — | 56,773,000USD | 19,605,000USD | 20,510,000USD | 21,381,000USD | 22,154,999USD | 22,965,000USD | 75,555,000USD |
| Non Current Liabilities Other | — | 388,000USD | 1,094,000USD | 1,091,000USD | 1,090,000USD | 1,006,000USD | 969,000USD | 1,012,000USD |
| Non Currrent Assets Other | — | 15,964,000USD | 4,136,000USD | 3,208,999USD | 3,567,000USD | 3,246,999USD | 7,865,000USD | 6,504,000USD |
| Net Working Capital | — | 358,543,000USD | 327,161,000USD | 369,190,000USD | 251,250,000USD | 281,090,000USD | 180,998,000USD | 136,401,000USD |
| Unclassified Non Current Assets | — | -10,556,000USD | — | 1,089,000USD | 1,089,000USD | 1,089,000USD | 1,088,000USD | 1,088,000USD |
| Unclassified Non Current Liabilities | — | 17,552,000USD | 18,511,000USD | 19,419,000USD | 20,291,000USD | 21,148,999USD | 21,996,000USD | 22,795,000USD |
| Unclassified Equity | — | 855,491,000USD | 844,305,000USD | 834,250,000USD | 687,042,000USD | 683,193,000USD | 555,327,000USD | 413,221,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Total Assets | 397,127,000USD | 240,542,000USD | 71,504,000USD | 149,957,000USD |
| Other Current Assets | 7,800,000USD | 4,859,000USD | 4,952,000USD | 6,230,000USD |
| Total Liab | 42,161,000USD | 43,638,000USD | 61,450,000USD | 48,514,000USD |
| Total Stockholder Equity | 354,966,000USD | 196,904,000USD | 10,054,000USD | 101,443,000USD |
| Other Current Liab | 15,967,000USD | 14,102,000USD | 9,807,999USD | 14,874,000USD |
| Common Stock | 49,000USD | 2,000USD | 22,000USD | 21,000USD |
| Capital Stock | 49,000USD | 2,000USD | 2,000USD | 2,000USD |
| Retained Earnings | -489,547,000USD | -358,427,000USD | -395,686,000USD | -295,271,000USD |
| Cash | 189,247,000USD | 196,812,000USD | 29,158,000USD | 99,919,000USD |
| Cash And Short Term Investments | 341,917,000USD | 196,812,000USD | 29,158,000USD | 99,919,000USD |
| Total Current Assets | 349,717,000USD | 201,671,000USD | 34,110,000USD | 106,149,000USD |
| Total Current Liabilities | 22,556,000USD | 20,673,000USD | 16,315,999USD | 20,783,000USD |
| Net Debt | -165,941,000USD | -170,184,000USD | 20,465,000USD | -67,864,000USD |
| Short Term Debt | 4,795,000USD | 4,632,000USD | 4,489,000USD | 4,324,000USD |
| Short Long Term Debt Total | 23,306,000USD | 26,628,000USD | 49,623,000USD | 32,055,000USD |
| Long Term Investments | 18,114,000USD | 0USD | — | — |
| Short Term Investments | 152,670,000USD | 0USD | — | — |
| Net Receivables | 1,500,000USD | — | — | — |
| Accounts Payable | 1,794,000USD | 1,939,000USD | 2,019,000USD | 1,585,000USD |
| Property Plant Equipment Net | 25,160,000USD | 29,918,000USD | 34,984,000USD | 41,228,000USD |
| Property Plant Equipment Gross | 44,371,000USD | 46,785,000USD | 48,770,000USD | 50,926,000USD |
| Accumulated Other Comprehensive Income | 110,000USD | — | — | — |
| Common Stock Shares Outstanding | 42,976,024shares | 43,796,057shares | 43,776,978shares | 43,776,978shares |
| Non Current Assets Total | 47,410,000USD | 38,871,000USD | 37,394,000USD | 43,807,999USD |
| Non Current Liabilities Total | 19,605,000USD | 22,965,000USD | 45,134,000USD | 27,731,000USD |
| Non Current Liabilities Other | 1,094,000USD | 969,000USD | — | — |
| Non Currrent Assets Other | 4,136,000USD | 7,865,000USD | 1,322,000USD | 1,369,999USD |
| Net Working Capital | 327,161,000USD | 180,998,000USD | 17,794,000USD | 85,366,000USD |
| Unclassified Non Current Liabilities | 18,511,000USD | 21,996,000USD | 25,054,000USD | 27,731,000USD |
| Unclassified Equity | 844,305,000USD | 555,327,000USD | 405,716,000USD | 396,691,000USD |
| Unclassified Non Current Assets | — | 1,088,000USD | 1,088,000USD | 1,210,000USD |
| Long Term Debt | — | — | 20,080,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 835,000USD |
| Stock Based Compensation | 16,296,000USD |
| Change To Liabilities | -766,000USD |
| Change In Working Capital | -1,530,000USD |
| Operating Cash Flow | -54,166,000USD |
| Capital Expenditures | -200,000USD |
| Net Investments | -122,031,000USD |
| Investing Cash Flow | -122,231,000USD |
| Net Debt Issuance | 39,401,000USD |
| Unclassified Financing Cash Flow | 150,392,000USD |
| Financing Cash Flow | 189,793,000USD |
| Change In Cash | 13,396,000USD |
| End Cash Flow | 203,731,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -24,208,000USD | -34,568,000USD | -30,087,000USD | -33,679,000USD | -32,786,000USD | -29,579,000USD | -24,752,000USD | 139,056,000USD |
| Depreciation | 444,000USD | 499,000USD | 571,000USD | 649,000USD | 684,000USD | 705,000USD | 788,000USD | 854,000USD |
| Stock Based Compensation | 7,109,000USD | 6,073,000USD | 3,864,000USD | 3,237,000USD | 3,226,000USD | 2,851,000USD | 2,343,000USD | 2,142,000USD |
| Other Non Cash Items | 8,327,000USD | 577,000USD | -1,453,000USD | 779,000USD | 785,000USD | 2,540,000USD | 3,648,000USD | 567,000USD |
| Change To Account Receivables | -20,000,000USD | — | — | — | 0USD | — | — | — |
| Change In Working Capital | -23,676,000USD | -311,000USD | 2,463,000USD | -1,038,000USD | -1,425,000USD | 1,031,000USD | -5,232,000USD | 2,429,000USD |
| Total Cash From Operating Activities | -39,113,000USD | -27,730,000USD | -24,642,000USD | -30,052,000USD | -29,516,000USD | -22,452,000USD | -23,205,000USD | 145,048,000USD |
| Capital Expenditures | -93,000USD | -34,000USD | -68,000USD | -393,000USD | -299,000USD | -605,000USD | -103,000USD | -160,000USD |
| Free Cash Flow | -39,206,000USD | -27,764,000USD | -24,710,000USD | -30,445,000USD | -29,815,000USD | -23,057,000USD | -23,308,000USD | 144,888,000USD |
| Investments | 6,368,000USD | -103,353,000USD | -66,883,000USD | -393,000USD | -299,000USD | -605,000USD | -103,000USD | -160,000USD |
| Total Cashflows From Investing Activities | 6,275,000USD | -103,387,000USD | -66,883,000USD | -393,000USD | -299,000USD | -605,000USD | -103,000USD | -160,000USD |
| Net Borrowings | 39,401,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | — |
| Total Cash From Financing Activities | 42,357,000USD | 3,590,000USD | 143,757,000USD | 612,000USD | 127,378,000USD | 70,262,000USD | -2,150,000USD | 154,000USD |
| Issuance Of Capital Stock | 0USD | 163,000USD | 141,748,000USD | 612,000USD | 127,752,000USD | — | 0USD | 0USD |
| Change In Cash | 9,519,000USD | -127,527,000USD | 52,232,000USD | -29,833,000USD | 97,563,000USD | 47,205,000USD | -25,458,000USD | 145,042,000USD |
| Begin Period Cash Flow | 189,247,000USD | 317,862,000USD | 265,630,000USD | 295,463,000USD | 197,900,000USD | 150,695,000USD | 176,153,000USD | 31,111,000USD |
| End Period Cash Flow | 198,766,000USD | 190,335,000USD | 317,862,000USD | 265,630,000USD | 295,463,000USD | 197,900,000USD | 150,695,000USD | 176,153,000USD |
| Other Cashflows From Financing Activities | 42,357,000USD | 3,590,000USD | 272,121,000USD | — | -374,000USD | 16,176,000USD | -2,150,000USD | -105,000USD |
| Unclassified Operating Cash Flow | -7,109,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -39,401,000USD | — | -270,112,000USD | — | — | 54,086,000USD | — | — |
| Sale Purchase Of Stock | — | 644,000USD | — | 612,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD |
|---|---|---|---|---|
| Net Income | -131,120,000USD | 52,231,000USD | -100,415,000USD | -114,940,000USD |
| Depreciation | 2,403,000USD | 3,297,000USD | 4,089,000USD | 3,820,000USD |
| Stock Based Compensation | 16,400,000USD | 9,646,000USD | 8,747,000USD | 6,736,000USD |
| Other Non Cash Items | 2,650,000USD | 12,303,000USD | 7,068,000USD | 8,417,000USD |
| Change In Working Capital | -2,273,000USD | -1,523,000USD | -6,316,000USD | -3,236,000USD |
| Total Cash From Operating Activities | -111,940,000USD | 75,954,000USD | -86,827,000USD | -99,203,000USD |
| Capital Expenditures | -794,000USD | -1,147,000USD | -441,000USD | -1,966,000USD |
| Free Cash Flow | -112,734,000USD | 74,807,000USD | -87,268,000USD | -101,169,000USD |
| Investments | -170,168,000USD | -1,147,000USD | -441,000USD | -3,170,000USD |
| Total Cashflows From Investing Activities | -170,962,000USD | -1,147,000USD | -441,000USD | -3,170,000USD |
| Net Borrowings | 0USD | 24,475,000USD | 16,176,000USD | 0USD |
| Total Cash From Financing Activities | 275,337,000USD | 92,847,000USD | 16,385,000USD | 1,728,000USD |
| Sale Purchase Of Stock | 1,256,000USD | — | — | — |
| Issuance Of Capital Stock | 270,275,000USD | 70,793,000USD | 0USD | 1,574,000USD |
| Change In Cash | -7,565,000USD | 167,654,000USD | -70,883,000USD | -100,645,000USD |
| Begin Period Cash Flow | 197,900,000USD | 30,246,000USD | 101,129,000USD | 201,774,000USD |
| End Period Cash Flow | 190,335,000USD | 197,900,000USD | 30,246,000USD | 101,129,000USD |
| Other Cashflows From Financing Activities | -500,000USD | 68,372,000USD | 209,000USD | 1,728,000USD |
| Unclassified Financing Cash Flow | 274,581,000USD | -70,793,000USD | — | -1,574,000USD |
| Unclassified Investing Cash Flow | — | 1,147,000USD | — | 1,966,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.